Butterfly Network, Inc. and Mendaera announced an agreement to commercialize a novel robotic system that is Powered by Butterfly's Ultrasound-on-Chip technology. Upon commercialization, the deal includes revenue share for every unit sold. Mendaera's robotic technology is compatible with Butterfly's proprietary semiconductor-based ultrasound device and connected via Butterfly's software development kit - Butterfly Garden??

- creating a system designed to improve precision and consistency for a broad range of image-guided, needle-based interventions. This new category of robotics will increase access to high quality interventional treatment, ultimately aiming to streamline patient care within a healthcare system burdened by workforce shortages and burnout. Both companies anticipate FDA submission of the product by 2025.